A working list of startups operating in the commonwealth, with ecosystem organizations available as separate views. Search, sort, filter — submit additions anytime.
10 of 466
#Company↑SectorStageFoundedDescriptionRegion
001
Acumen Pharmaceuticals
Pharmaceutical company focused on developing treatments.
Biotech—1996Pharmaceutical company focused on developing treatments.CVL→
002
AgroSpheres
AgBiotech developing novel delivery system for safer, more effective pesticide delivery using Minicell bioparticle technology. 25+ employees.
BiotechSeries B2016AgBiotech developing novel delivery system for safer, more effective pesticide delivery using Minicell bioparticle technology. 25+ employees.CVL→
003
BUILT Biotechnologies
Regenerative DNA Assembly process for DNA synthesis and manufacturing-as-a-service.
BiotechSeed2021Regenerative DNA Assembly process for DNA synthesis and manufacturing-as-a-service.CVL→
004
Cerillo, Llc
Cerillo, Llc is a Charlottesville, Virginia-based company.
Biotech—2016Cerillo, Llc is a Charlottesville, Virginia-based company.CVL→
005
CvilleBioHub member: Diffuse Bio
Generative AI for protein and small-molecule design.
BiotechPre-seed2023Generative AI for protein and small-molecule design.CVL→
006
HemoShear Therapeutics
Human-relevant disease models for rare metabolic diseases and pharma partnerships.
BiotechSeries B2008Human-relevant disease models for rare metabolic diseases and pharma partnerships.CVL→
007
Hyperion Bio
Single-cell sequencing instruments and reagents (UVA spinout).
BiotechSeed2022Single-cell sequencing instruments and reagents (UVA spinout).CVL→
008
Lumacyte
Lumacyte is a Virginia-based company focusing on rapid label-free single cell analysis.
Biotech——Lumacyte is a Virginia-based company focusing on rapid label-free single cell analysis.CVL→
009
Rivus Pharmaceuticals
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
BiotechSeries B2019Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.CVL→
010
TearSolutions
Developing therapies for dry eye disease.
Biotech——Developing therapies for dry eye disease.CVL→